Corinne Perreau

The small leucine-rich proteoglycan lumican inhibits melanoma progression

Boris Vuillermoz, Marie-France D’Onofrio, Laurent Ramont et al. · Experimental Cell Research · 2004 · 133 citations

Medicine, Cancer Biology, Oncology +12

Lumican inhibits cell migration through α2β1 integrin

Cédric Zeltz, Stéphane Brézillon, Jarmo Käpylä et al. · Experimental Cell Research · 2010 · 85 citations

Life Sciences, Cell Biology, Molecular Biology +14

Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal transition

Marco Franchi, Zoi Piperigkou, Corinne Perreau et al. · Scientific Reports · 2017 · 75 citations · Full text

Medicine, Cell Biology, Oncology +17

Lumican: A new inhibitor of matrix metalloproteinase‐14 activity

Katarzyna Pietraszek‐Gremplewicz, Aurore Chatron-Colliet, Stéphane Brézillon et al. · FEBS Letters · 2014 · 72 citations · Full text

Medicine, Cancer Biology, Oncology +11

Expression of lumican, a small leucine-rich proteoglycan with antitumour activity, in human malignant melanoma

Stéphane Brézillon, Lydie Ventéo, Laurent Ramont et al. · Clinical and Experimental Dermatology · 2007 · 69 citations

Medicine, Biochemistry, Oncology +14